Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

News & Events

Tillotts Pharma AG signs license agreement on antibody technology with Inven2

Press Release

Tillotts Pharma AG signs license agreement on antibody technology with Inven2

RHEINFELDEN, Switzerland, January 22, 2018 Inven2 AS (Inven2), a technology transfer an[...] Read more »
The Value of Collaboration in IBD

News

The Value of Collaboration in IBD

In an article recently published by PharmaTimes Online, Tillotts Pharma UK General Manager[...] Read more »
Tillotts Pharma successfully completes DCP<sup>1</sup> for Colpermin™ in Europe

News Press Release

Tillotts Pharma successfully completes DCP1 for Colpermin™ in Europe

Press Release RHEINFELDEN, Switzerland, Nov. 29 2017 – Tillotts Pharma AG (“Tillott[...] Read more »
Rewarding the extraordinary – An evening at the Baloise Session

News

Rewarding the extraordinary – An evening at the Baloise Session

At Tillotts Pharma, we are looking for extraordinary employees who are willing to contribu[...] Read more »
Tillotts Pharma: Positive Results of Largest Phase III Clinical Trial of Mesalazine Induction Therapy Published

News Press Release

Tillotts Pharma: Positive Results of Largest Phase III Clinical Trial of Mesalazine Induction Therapy Published

PRESS RELEASE Not for distribution in Czech Republic, France, Ireland, Spain, Sweden and [...] Read more »
A small fish in the big pond

News Press Release

A small fish in the big pond

CEO Thomas A. Tóth von Kiskér and Head of HR Gabriella Schraner were interviewed for the[...] Read more »
1 10 11 12 13 14 22